Agios Pharmaceuticals, Inc. financial data

Symbol
AGIO on Nasdaq
Location
88 Sidney Street, Cambridge, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.06K % -22.2%
Quick Ratio 32.1 % +14.7%
Debt-to-equity 11.1 % -15.2%
Return On Equity 58.9 %
Return On Assets 53.1 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 57.3M shares +1.96%
Common Stock, Shares, Outstanding 57.2M shares +2.17%
Entity Public Float 2.42B USD +55.1%
Weighted Average Number of Shares Outstanding, Basic 56.8M shares +2.08%
Weighted Average Number of Shares Outstanding, Diluted 57.9M shares +4.02%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 36.5M USD +36.1%
Research and Development Expense 301M USD +1.95%
Costs and Expenses 462M USD +10.5%
Operating Income (Loss) -426M USD -8.75%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1B USD
Income Tax Expense (Benefit) 53.1M USD
Net Income (Loss) Attributable to Parent 674M USD -0.61%
Earnings Per Share, Basic 11.9 USD/shares +3.51%
Earnings Per Share, Diluted 11.6 USD/shares +15.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 76.2M USD -13.6%
Cash, Cash Equivalents, and Short-term Investments 1.5B USD +86%
Inventory, Net 27.6M USD +44.8%
Assets, Current 966M USD +15.8%
Property, Plant and Equipment, Net 11.7M USD -24.1%
Operating Lease, Right-of-Use Asset 42.9M USD -21.2%
Other Assets, Noncurrent 4.72M USD +16.4%
Assets 1.66B USD +77.5%
Accounts Payable, Current 16.6M USD +70.2%
Employee-related Liabilities, Current 29.9M USD +28.9%
Accrued Liabilities, Current 46.9M USD +8.56%
Liabilities, Current 81.2M USD +19.4%
Operating Lease, Liability, Noncurrent 40.2M USD -29.4%
Other Liabilities, Noncurrent 880K USD -23.9%
Liabilities 122M USD -3.06%
Retained Earnings (Accumulated Deficit) -149M USD +81.9%
Stockholders' Equity Attributable to Parent 1.54B USD +90%
Liabilities and Equity 1.66B USD +77.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -99.9M USD -4.92%
Net Cash Provided by (Used in) Financing Activities 5.86M USD +138%
Net Cash Provided by (Used in) Investing Activities 125M USD +116%
Common Stock, Shares Authorized 125M shares 0%
Common Stock, Shares, Issued 73.4M shares +1.68%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 30.6M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 76.2M USD -13.6%
Deferred Tax Assets, Valuation Allowance 276M USD -27.4%
Deferred Tax Assets, Gross 287M USD -27.2%
Operating Lease, Liability 57M USD -20.8%
Payments to Acquire Property, Plant, and Equipment 141K USD -64.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 673M USD -12.1%
Lessee, Operating Lease, Liability, to be Paid 62.3M USD -23.1%
Property, Plant and Equipment, Gross 68.2M USD +0.83%
Operating Lease, Liability, Current 16.8M USD +11.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 20.2M USD +3.31%
Lessee, Operating Lease, Liability, to be Paid, Year One 17.9M USD +4.67%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.34M USD -40.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 20.8M USD +3%
Deferred Tax Assets, Operating Loss Carryforwards 26.5M USD -58.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Unrecognized Tax Benefits 31.6M USD +10.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.48M USD -83.2%
Operating Lease, Payments 18.7M USD +2.94%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 42.8M USD -4.29%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%